Compound Detail

CHEMBL4530619

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

COc1ccc(OC)c(S(=O)(=O)N2CCC(N3CCC(C)CC3)CC2)c1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4530619
Phase	Preclinical
Structure Type	MOL
InChI Key	GSIJXUXLBIMFDI-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

382.5

MW (Da)

2.59

ALogP

HBA

HBD

59.1

PSA (Å²)

0.78

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 3 meas. best 8.4

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HT-29 CHEMBL384	IC50	8.4	8.4	4.0	1
DLD-1 CHEMBL614285	IC50	8.35	8.35	4.5	1
Unchecked CHEMBL612545	IC50	7.98	7.98	10.5	1

Parameter	Value	Units	Species
T1/2	0.1567	hr	Mus musculus

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HT-29	IC50	=	4.0	nM	8.4	Antiproliferative activity against human HT-29 cells after 72 hrs by Celltiter-G...	31070915
DLD-1	IC50	=	4.5	nM	8.35	Antiproliferative activity against human DLD1 cells after 72 hrs by Celltiter-Gl...	31070915
Unchecked	IC50	=	10.5	nM	7.98	Antiproliferative activity against human CTRPA cells harboring APC A1309 mutant ...	31070915

PubMed	DOI	Target Context	# Activities
31070915	10.1021/acs.jmedchem.9b00532	Unchecked	2
31070915	10.1021/acs.jmedchem.9b00532	DLD-1	1
31070915	10.1021/acs.jmedchem.9b00532	HCT-116	1
31070915	10.1021/acs.jmedchem.9b00532	ADMET	1
31070915	10.1021/acs.jmedchem.9b00532	HT-29	1

Data from ChEMBL 36 via Core Engine